Search for: "Teva Pharmaceutical"
Results 441 - 460
of 1,424
Sort by Relevance
|
Sort by Date
13 Jun 2017, 12:00 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
8 Jun 2017, 3:27 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit had its first opportunity to address the impact of the “or otherwise available to the public” clause contained in post-AIA 35 U.S.C. [read post]
28 May 2017, 8:19 pm
Biosig Instruments, Inc. and Teva Pharmaceuticals USA, Inc. v. [read post]
25 May 2017, 6:20 pm
A post concerning future generic "Copaxone" at raps.org beginsGeneric versions of Teva's multi-billion-dollar per year multiple sclerosis drug Copaxone (glatiramer) are coming, but a closer look at which competitor might win the coveted 180-day exclusivity for its generic reveals an unusual and complex situation.Back in January, a US District Court for the District of Delaware ruling invalidated all asserted claims on Teva's patents on its 40mg version of… [read post]
18 May 2017, 1:55 pm
Teva Pharmaceuticals (Fed. [read post]
9 May 2017, 4:42 am
Arnold J. reiterated his view (expressed previously in Teva UK Ltd v Gilead Sciences Inc [2017] EWHC 13 (Pat)) that the test in Lilly remains unclear. [read post]
4 May 2017, 8:26 am
(“Helsinn”) brought suit against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. [read post]
4 May 2017, 8:26 am
(“Helsinn”) brought suit against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. [read post]
2 May 2017, 3:51 am
Teva Pharmaceuticals (Fed. [read post]
1 May 2017, 12:44 pm
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel of Judges Dyk, Mayer and O’Malley determined: “after the AIA, if the […] The post CAFC Interprets AIA On-Sale Bar: Invention details need not be public for sale to be invalidating appeared first on... [read post]
1 May 2017, 10:58 am
:Helsinn brought suit against Teva PharmaceuticalsUSA, Inc. and Teva Pharmaceutical Industries, Ltd. [read post]
30 Apr 2017, 10:00 pm
Teva, the Federal Circuit added greater clarity to the restrictions the sale of inventions pose to patentability. [read post]
12 Apr 2017, 10:32 am
Defendants are Actavis LLC of Parsippany, New Jersey; Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania; and Teva Pharmaceutical Industries, Ltd. of Petach Tikva, Israel. [read post]
12 Apr 2017, 10:32 am
Defendants are Actavis LLC of Parsippany, New Jersey; Teva Pharmaceuticals USA, Inc. of North Wales, Pennsylvania; and Teva Pharmaceutical Industries, Ltd. of Petach Tikva, Israel. [read post]
12 Apr 2017, 7:13 am
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED April 10, 2017, Order) (Bryson, CJ) [read post]
6 Apr 2017, 1:35 pm
Teva Pharms. [read post]
3 Apr 2017, 9:59 pm
Teva Pharmaceuticals USA, Inc. v. [read post]
31 Mar 2017, 7:35 am
So how does the decision in Teva v MSD fit into this? [read post]
25 Mar 2017, 4:00 am
In 2010, the Whiteners sued PLIVA, Inc., Barr Laboratories, Inc., Teva Pharmaceutical Industries, Ltd., Alaven Pharmaceutical L.L.C., Meda Pharmaceuticals, Inc., and Schwarz Pharma, Inc. [read post]
8 Mar 2017, 8:03 pm
Because we see no error in these rulings, we affirmthe district court’s entry of judgment against Sprint.Teva gets cited as to "claim construction":The proper construction of a patent’s claims is an issueof Federal Circuit law, and we apply the frameworkset forth in Teva Pharmaceuticals USA, Inc. v. [read post]